Prevention of preeclampsia with calcium supplementation and vitamin D3 in an antenatal protocol

Int J Gynaecol Obstet. 1994 Nov;47(2):115-20. doi: 10.1016/0020-7292(94)90350-6.

Abstract

Objectives: Using an angiotensin sensitivity test we carried out a prospective study in an attempt to predict the possible onset of preeclampsia and to prevent it by calcium supplementation (elemental calcium 156 or 312 mg/day per os) and treatment with vitamin D3 (0.5 micrograms/3 day per os).

Method: We used a study design in which 666 singleton pregnant women were managed with conventional antenatal care and 210 singleton pregnant women were managed with a protocol, together with conventional antenatal care.

Result: Of the 666 women managed conventionally, 113 (16.9%) developed preeclampsia. However, the incidence of preeclampsia in the 210 women managed on the protocol was lower, at 10.9%.

Conclusion: Our findings indicate that this protocol for the prediction and prevention of preeclampsia is useful for pregnant women at high risk of developing preeclampsia.

Publication types

  • Clinical Trial
  • Comparative Study
  • Controlled Clinical Trial
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adult
  • Angiotensin II
  • Blood Pressure / drug effects
  • Calcium / therapeutic use*
  • Causality
  • Cholecalciferol / therapeutic use*
  • Clinical Protocols
  • Female
  • Humans
  • Incidence
  • Parity
  • Pre-Eclampsia / diagnosis
  • Pre-Eclampsia / epidemiology
  • Pre-Eclampsia / prevention & control*
  • Pregnancy
  • Pregnancy, High-Risk
  • Prospective Studies

Substances

  • Angiotensin II
  • Cholecalciferol
  • Calcium